
EDITORIAL: I-Base funding update
HIV Treat Bull 2008 May-June 9(5/6);
First of all, thank you to everyone who wrote to the commissioners expressing your concern about our withdrawn TIPI funding.
We are concerned that the standard reply that many of you received from Hong Tan is pretty misleading.
Firstly, it implies that the total funding has been increased. This is not true. The budget for services to HIV-positive people has actually been cut from around £600,000 per year to £400,000 per year. We do not think most HIV-positive people or service providers are aware of this.
Secondly, it talks about the openess of the tender process. Ths was not our experience. The public consultation meetings, for example, were arranged at short notice and with no emphasis on the services for HIV-positive people. They focused almost exclusively on prevention programmes. We can see no transparency between our community responses and the final tender decisions.
Thirdly, the Commissioners are defending the fairness of their process, rather than look at the problems behind the original commisioning intentions. We are interested in how our readers feel about the proposal to spend half the, now reduced, budget (£200,000) on a new healthcare trainer programme that duplicates services already being provided by NHS clinics?
The remaining £200,000 was awarded to one provider to meet all the information needs of every London patient. Are readers happy with this lack of choice? Do we really need 15 treatment booklets and for one provider to be to only source of information?
Unfortunately, the tender process has:
We would like to continue the pressure to change this outcome.
If you use or have used i-Base services as a London patient or clinic, please email letters of support to:
Ray.Appleby@kc-pct.nhs.uk
Hong.Tan@londonscg.nhs.uk
Please copy any correspondence to:
Simon.Collins@i-Base.org.uk
Finally, Hong Tan has kindly advised us to seek national funding (as if we hadn’t thought of that). So for potential funders, the following information details the scope and cost effectness of the projects that we are now looking to fund. None of the following modestly budgeted projects interest the Commissioners. They are confident that they are not needed or will be covered in the new tenders.
The i-Base Introduction to Combination Therapy is updated annualy, is widely used and includes information for pateints to record their results. It costs less than £1 per copy and £4,500 for London patients.
Community treatment workshops to work with existing support organisations, especially African organisations where the social aspect of these networks is essential, but also never address by the TIPI tender; Total project cost: £7,500
Ten meetings a year @ £750 per meeting for 40 attendees (average 30-50). £650 per meeting will meet direct costs for travel and refreshments. i-Base speaker cost £100 per workshop. Unit cost per person per workshop - £18.75
The i-Base website costs £24,000 to maintain and develop annually. This includes all i-Base publications, translations of different resources into 20 languages, interactive learning resources and an interactive Q&A section.
New guide to avoiding and managing side effects
Sorry to burden you but we have included one of our new unnecessary booklets with this issue of HTB.
As with all publications, the updated i-Base Guide to Avoiding and Managing Side Effects is available free, including in bulk. to individuals and clinics.
Please use the order form on the back page or order directly online.
Despite the current funding issues, we will continue to provide all services and publications free.
Donations are of course welcome, but at least you will know that your your taxes didn’t pay for them.
2008-05-10
IB080905-01
©2008. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.